Showing results (331-340 of 367) with videos related to

Sort By:
Pageof 37
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Vaccine|July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021Peter J Embi, Matthew E Levy, Palak Patel, et al.
Lancet (London, England)|March 18, 2020
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USAIsaac Ghinai, Tristan D McPherson, Jennifer C Hunter, et al.
Public Health Reports (Washington, D.C. : 1974)|October 28, 2020
Lack of Serologic Evidence of Infection Among Health Care Personnel and Other Contacts of First 2 Confirmed Patients With COVID-19 in Illinois, 2020Tristan D McPherson, Isaac Ghinai, Alison M Binder, et al.
MMWR. Morbidity and Mortality Weekly Report|March 15, 2023
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
BMJ (Clinical Research Ed.)|October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyJill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Lancet Regional Health. Americas|October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysisAmanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
JAMA Network Open|June 25, 2025
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in AdultsRuth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Lancet (London, England)|October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysisAmanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
Pageof 37